Prevention of postmenopausal bone loss by low and conventional doses of calcitriol or conjugated equine estrogen

Maturitas

Volumn 34, Issue 2, 2000, Pages 179-184

  Ongphiphadhanakul, B ^a   Piaseu, N ^a   Tung, S Sae ^a   Chailurkit, L ^a   Rajatanavin, R ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Bone loss; Calcitriol; Estrogen; Menopause; Osteoporosis

Indexed keywords

CALCITRIOL; CALCIUM CARBONATE; CONJUGATED ESTROGEN; MEDROGESTONE;

ADULT; ARTICLE; BONE ATROPHY; CLINICAL TRIAL; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE;

BONE DENSITY; CALCITRIOL; CALCIUM; CALCIUM CHANNEL AGONISTS; DENSITOMETRY, X-RAY; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; FEMUR NECK; FOLLOW-UP STUDIES; HUMANS; LUMBAR VERTEBRAE; MEDROGESTONE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; PROGESTERONE CONGENERS; THAILAND;

EQUIDAE; THAIS;

EID: 0033973264     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(99)00091-2     Document Type: Article

References (21)

1. Lindsay R., Hart D.M., Aitken J.M., Anderson J.B., MacDonald E.B., Clarke A.C. Long-term prevention of postmenopausal osteoporosis by oestrogen. Lancet. i:1976;1038-1041.
2. Christiansen C., Christiansen M.S., McNair P., Hagen C., Stocklund K.E., Transbol I. Prevention of early postmenopausal bone loss: conducted 2 years study in 315 normal females. Eur. J. Clin. Invest. 10:1980;273-279.
3. Heaney R.P., Recker R.R., Stegman M.R., Moy A.J. Calcium absorption in women: relationships to calcium intake, estrogen status, and age. J. Bone Miner. Res. 4:1989;469-475.
4. Tsai K.S., Wahner H.W., Offord K.P., Melton L.J. III, Kumar R., Riggs B.L. Effect of aging on vitamin D stores and bone density in women. Calcif. Tissue Int. 40:1987;241-243.
5. 3 and intestinal vitamin D receptor concentrations in normal women. J. Clin. Endocrinol. Metab. 75:1992;176-182.
6. Pacifici R., Brown C., Puscheck E. et al. Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc. Natl. Acad. Sci. USA. 88:1991;5134-5138.
7. Jilka R.L., Hangoc G., Girasole G. et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science. 257:1992;88-91.
8. Ettinger B., Genant H.K., Cann C.E. Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium. Ann. Intern. Med. 106:1987;40-45.
9. Genant H.K., Lucas J., Weiss S. et al. Low-dose esterified estrogen therapy: effects on bone, plasma estradiol concentrations, endometrium, and lipid levels. Estratab/Osteoporosis Study Group. Arch. Intern. Med. 157:1997;2609-2615.
10. Cummings S.R., Browner W.S., Bauer D. et al. Endogenous hormones and the risk of hip and vertebral fractures among older women. New Engl. J. Med. 339:1998;733-738.
11. van Hoff J.H.C., van der Mooren M.J., Swinkels L.M.J., Rolland R., Benraad T.J. Hormone replacement therapy increases serum 1,25-dihydroxyvitamin D: a 2-year prospective study. Calcif. Tissue Int. 55:1994;417-419.
12. 3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis. Eur. J. Clin. Invest. 11:1981;305-309.
13. 3 and calcium. Clin. Endocrinol. 16:1982;515-524.
14. Komulainen M., Tuppurainen M.T., Kroger H. et al. Vitamin D and HRT: no benefit additional to that of HRT alone in prevention of bone loss in early postmenopausal women. A 2.5-year randomized placebo-controlled study. Osteoporos. Int. 7:1997;126-132.
15. Gallagher J.C., Jerpbak C.M., Jee W.S., Johnson K.A., DeLuca H.F., Riggs B.L. 1,25-dihydroxyvitamin D3: short- and long-term effects on bone and calcium metabolism in patients with postmenopausal osteoporosis. Proc. Natl. Acad. Sci. USA. 79:1982;3325-3329.
16. Tilyard M.W., Spears G.F.S., Thomson J., Dovey S. Treatment of postmenopausal osteoporosis with calcitriol or calcium. New Engl. J. Med. 3326:1992;357-362.
17. Ott S.M., Chesnut C.H. Calcitriol treatment is not effective in postmenopausal osteoporosis. Ann. Intern. Med. 110:1989;267-274.
18. Cooper G.S., Umbach D.M. Are vitamin D receptor polymorphisms associated with bone mineral density? A meta-analysis. J. Bone Miner. Res. 11:1996;1841-1849.
19. Howard G., Nguyen T., Morrison N. et al. Genetic influences of bone density: physiological correlates of vitamin D receptor gene alleles in premenopausal women. J. Clin. Endocrinol. Metab. 80:1995;2800-2805.
20. Dawson-Hughes B., Harris S.S., Finneran S. Calcium absorption on high and low calcium intakes in relation to vitamin D receptor genotype. J. Clin. Endocrinol. Metab. 80:1995;3657-3661.
21. Garabedian M., Tanaka Y., Holick M.F., Deluca H.F. Response of intestinal calcium transport and bone calcium mobilization to 1,25-dihydroxyvitamin D3 in thyroparathyroidectomised rats. Endocrinology. 94:1974;1022-1027.